A 57-year-old Japanese man was admitted to our hospital with diarrhea, weight loss and malabsorption. Due to a high serum IgA level, we suspected α-heavy chain disease (α-HCD). However, no monoclonal IgA was detected on protein electrophoresis or immunofixation. Immunohistochemical staining of intestinal biopsy specimens showed proliferation of CD138 + IgA + cells, compatible with a diagnosis of α-HCD. Most α-HCD patients exhibit M-proteins in the serum on electrophoresis or immunoelectrophoresis; however, some patients lack detectable M-proteins, similar to our patient. Therefore, when α-HCD is suspected based on the clinical features, immunohistochemistry is required to make a diagnosis.
Introduction
α-Heavy chain disease (α-HCD) is a lymphoproliferative disease in which monoclonal α-heavy chain proteins lacking light chain (κ or λ) proteins are produced. In 1968, Seligmann et al. first reported that plasma cells in the intestinal lamina propria produced monoclonal α-heavy chain proteins in a patient with Mediterranean lymphoma (1) .
α-HCD is classified into three types according to the anatomical site: digestive, respiratory and lymphoid (2) . The digestive type is a synonym for immunoproliferative small intestinal disease (IPSID) and primarily affects children and young adults (range, 10-35 years; mean, 25-30 years) of low socioeconomic status in developing countries (3) . The clinical characteristics of the digestive type include weight loss, intermittent diarrhea, abdominal pain lasting for months to years, malabsorption and, in serious cases, intestinal obstruction, abdominal mass formation and ascites (4) .
α-Heavy chain proteins in patients with the digestive type of the disease are usually found as M-proteins in the serum, urine, saliva and intestinal juice on electrophoresis or immunoelectrophoresis (3). Therefore, the detection of M-proteins is a clue for the diagnosis. The typical histological finding of α-HCD of the digestive type is monoclonal proliferation of lymphocytes and/or plasma cells. A conclusive diagnosis of digestive-type α-HCD is made based on the detection of α-heavy chain proteins using immunohistochemistry of tissue samples unrelated to the disease progression. We herein report the case of a Japanese α-HCD patient with severe enteropathy in whom making a definitive diagnosis was difficult due to the lack of detectable M-proteins.
Case Report
A 57-year-old Japanese man was admitted to our hospital three years ago with diarrhea, a three-year history of body weight loss and pitting edema of the legs. Two months before admission, he exhibited hypoalbuminemia, a high level of soluble IL-2 receptor and celiac lymphadenopathy, and physicians suspected a diagnosis of protein-losing enteropathy or malignant lymphoma. However, positron emission tomography/computed tomography (PET/CT) did not reveal significant accumulation of FDG. Furthermore, upper gastrointestinal endoscopy, colonoscopy and biopsy specimens did not indicate malignant lymphoma. Thereafter, the patient's diarrhea, weight loss and edema gradually worsened, and upper gastrointestinal endoscopy disclosed candida esophagitis. He was admitted to our hospital to determine the cause of the protein-losing enteropathy and diarrhea. The patient's body weight was 39.9 kg and his body mass index (BMI) was 14.53. There was no lymph node swelling; however, edema was present. The results of the laboratory tests are shown in Table 1 . The level of serum IgA was elevated (normal: 110-410 mg/dL), with decreased IgG and IgM levels. Electrophoresis of serum protein showed a polyclonal peak from the α2 fraction to the γ fraction. Immunoelectrophoresis lacked a monoclonal band (Fig. 1a ). An abdominal contrast CT scan indicated ascites and an edematous stomach wall. Capsule endoscopy revealed a slightly rough mucosa with swelling of the villi within the small intestine and a scar from a longitudinal ulcer extending from the superior jejunum to the middle ileum (Fig. 2) . However, neither active ulcers nor hemorrhage were found. A microscopic examination of the biopsy specimens demonstrated marked infiltration of inflammatory-like cells; the cells were mostly lymphocytes and plasma cells in the mucosa of the stomach, duodenum, jejunum and ileum (Fig. 1) . Although Hematoxilin and Eosin (H/E) staining showed no defective malignant characteristics, immunohistochemical staining revealed that the infiltrated inflammatory-like cells were positive for CD138 and IgA and negative for CD20, IgG and IgM. These cells showed no significant κ/λ laterality. Therefore, we diagnosed the patient with α-HCD, digestive type, stage B and initiated chemotherapy with CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) according to the protocol for treating non-Hodgkin's lymphoma (Fig. 3) . After a single course of chemotherapy, the patient exhibited a marked decrease in the IgA level and improvements in malabsorption and oral ingestion. After the third course of CHOP, his condition was complicated by heart failure, and the chemotherapy could not be continued; therefore, he was moved to a hospital near his home.
Discussion
α-HCD is a rare lymphoproliferative disease that can cause severe enteropathy. For the diagnosis, the detection of α-heavy chain proteins as M-proteins is informative. α-Heavy chain proteins are proteins with a molecular weight between 29,000 and 34,000. α-Heavy chain proteins in α-HCD patients are usually detected as M-proteins on electrophoresis or immunoelectrophoresis of the serum, urine, saliva or intestinal juice (3) . In the present case, we were unable to confirm the presence of serum or urine M-proteins. As shown in Table 2 , three Japanese patients with digestive disease lacking M-proteins have previously been reported. In these cases, it was supposed that α-heavy chain proteins accumulated and polymerized during disease progression, as polymerized α-heavy chain proteins were found as polyclonal bands on electrophoresis or immunoelectrophoresis (5) . Therefore, M-proteins may be detected following the reduc- tion of polymerized α-heavy chain proteins using 2-mercaptoethanol. However, we were unable to confirm the presence of M-proteins, despite using this method, in the present case (data not shown).
In previously reported α-HCD patients, endoscopic examinations of the small intestine often showed an edematous mucosa with enlarged villi, erosion and areas of ulceration (6-10). A cobblestone appearance with small nod- ules (9) or multiple granular/nodular lesions may be observed in the small intestine (7, 8, 11) . Although α-HCD primarily involves the small intestine, edema or erosion of the gastric mucosa may coexist, as noted in our patient (7) . A definitive diagnosis of α-HCD is made based on the detection of α-heavy chain proteins in the cytoplasm on immunohistochemistry. The typical histological findings of digestive-type α-HCD include monoclonal proliferation of lymphocytes and plasma cells, enlargement of villi and destruction of ducts during disease progression. The pathologic stages of α-HCD have been defined to be the early stage (stage A), intermediate stage (stage B) and late stage (stage C) (12, 13) . Stage A involves mature plasmacytic or lymphoplasmacytic infiltration of the mucosal lamina propria with inconstant and variable villous atrophy. Stage B includes atypical plasmacytic or lymphoplasmacytic infiltration associated with the presence of more or less atypical immunoblast-like cells extending at least to the submucosa and subtotal or total villous atrophy. Stage C is characterized by sarcomatous proliferation invading the whole depth of the intestinal wall. In the present case, although H/E staining showed the infiltration of inflammatory-like cells, immunohistochemical staining of the small intestinal mucosa demonstrated the pathological findings of stage B disease, and the presence of α-heavy chain proteins was diagnosed based on the difference between CD138 + IgA + and light chains, which were slightly positive in the cytoplasm of the cells. Therefore, we diagnosed the patient with α-HCD, digestive-type (ISPID), stage B. In conclusion, immunohistochemical staining for α-heavy chain proteins should be performed on biopsy specimens if a diagnosis of α-HCD is suspected based on the clinical characteristics, even when M-proteins are not detected.
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